Erlotinib Recruiting Phase 1 Trials for Lung Cancers

IndicationsStatusPurposePhase
RecruitingNot Available1
clinicaltrials.gov IdentifierTitleDrugs
NCT02321293A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC